CEVA, Inc. Files 8-K with Material Agreement Details
Ticker: CEVA · Form: 8-K · Filed: Nov 19, 2025 · CIK: 1173489
Sentiment: neutral
Topics: material-agreement, 8-k
TL;DR
CEVA filed an 8-K on Nov 17, 2025, reporting a material definitive agreement.
AI Summary
On November 17, 2025, CEVA, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial statements/exhibits. The company is incorporated in Delaware and its principal executive offices are located in Rockville, MD.
Why It Matters
This 8-K filing indicates a significant new agreement for CEVA, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's stock price.
Key Players & Entities
- CEVA, INC. (company) — Registrant
- November 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Rockville, MD (location) — Address of Principal Executive Offices
FAQ
What is the nature of the material definitive agreement filed by CEVA, Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on November 17, 2025.
Where are CEVA, Inc.'s principal executive offices located?
CEVA, Inc.'s principal executive offices are located at 15245 Shady Grove Road, Suite 400, Rockville, MD 20850.
What is CEVA, Inc.'s state of incorporation?
CEVA, Inc. is incorporated in Delaware.
What is the filing date of this 8-K report?
The 8-K report was filed as of November 19, 2025, with the earliest event reported on November 17, 2025.
Filing Stats: 730 words · 3 min read · ~2 pages · Grade level 9.2 · Accepted 2025-11-19 08:30:19
Key Financial Figures
- $0.001 — ge on which registered Common Stock , $0.001 par value CEVA The Nasdaq Global Mar
- $19.50 — Stock"), at a public offering price of $19.50. Pursuant to the terms of the Underwrit
Filing Documents
- ceva20251118_8k.htm (8-K) — 29KB
- ex_890640.htm (EX-1.1) — 190KB
- ex_890610.htm (EX-5.1) — 12KB
- ex_890437.htm (EX-99.1) — 13KB
- ex_890611.htm (EX-99.2) — 14KB
- mflogo.jpg (GRAPHIC) — 8KB
- 0001437749-25-035656.txt ( ) — 456KB
- ceva-20251117.xsd (EX-101.SCH) — 3KB
- ceva-20251117_def.xml (EX-101.DEF) — 12KB
- ceva-20251117_lab.xml (EX-101.LAB) — 15KB
- ceva-20251117_pre.xml (EX-101.PRE) — 12KB
- ceva20251118_8k_htm.xml (XML) — 3KB
01. Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement. On November 18, 2025, Ceva, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with J.P. Morgan Securities LLC, as representative of the underwriters (the "Underwriters"). Pursuant to the terms and conditions of the Underwriting Agreement, the Company agreed to sell 3,000,000 shares of its common stock, $0.001 par value per share ("Common Stock"), at a public offering price of $19.50. Pursuant to the terms of the Underwriting Agreement, the Company granted the Underwriters a 30-day option to purchase up to an additional 450,000 shares of Common Stock. The Common Stock was offered and sold pursuant to a prospectus supplement, dated November 18, 2025, and a shelf registration statement on Form S-3 (File No. 333-281323), which became effective on August 16, 2024. The closing of the offering is expected to occur on November 20, 2025. A copy of the Underwriting Agreement is filed herewith as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. The summary set forth above is qualified in its entirety by reference to Exhibit 1.1. Morrison & Foerster LLP, counsel to the Company, delivered an opinion as to the legality of the issuance and sale of Common Stock in the offering, a copy of which is attached hereto as Exhibit 5.1 and is incorporated herein by reference.
01. Other Events
Item 8.01. Other Events. On November 17, 2025, the Company issued a press release announcing the commencement of the offering, and on November 18, 2025, the Company issued a press release announcing the pricing of the offering. A copy of each press release is attached as Exhibit 99.1 and 99.2, respectively, to this Current Report on Form 8-K.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated November 18, 2025, by and among Ceva, Inc. and J.P. Morgan Securities LLC, as representative of the underwriters. 5.1 Opinion of Morrison & Foerster LLP regarding the legality of the Common Stock. 99.1 Press Release dated November 17, 2025, announcing the commencement of the offering. 99.2 Press Release dated November 18, 2025, announcing the pricing of the offering. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CEVA, INC. Date: November 18, 2025 By: /s/ Yaniv Arieli Yaniv Arieli Chief Financial Officer